Amedeo Smart

Free Medical Literature Service


 

Amedeo

Hypersensitivity Reaction

  Free Subscription

Articles published in
Dermatology
    February 2024
  1. VALEILLE A, Ouilhon C, Subtil F, Hacard F, et al
    Comprehensive ophthalmological evaluation in atopic dermatitis.
    Dermatology. 2024 Feb 14. doi: 10.1159/000536233.
    >> Share

    January 2024
  2. LEE HJ, Hong YJ, Han KD, Lee JH, et al
    Atopic Dermatitis Severity and Risk for Psoriasis: A Nationwide Population-Based Study.
    Dermatology. 2024 Jan 16. doi: 10.1159/000536143.
    >> Share

  3. YIN M, Yang C, Guo Y, Yang X, et al
    Comorbidities of Chronic Prurigo: A Systematic Review and Meta-Analysis.
    Dermatology. 2024;240:32-41.
    >> Share

  4. MEIENBERGER N, Maul JT, Frohlich F, Maul LV, et al
    Atypical and Typical Presentation of Erythema Nodosum: Clinical Differences in Treatment and Outcome.
    Dermatology. 2024;240:226-232.
    >> Share

    December 2023
  5. LI MC, Wu CY, Chang YT, Lyu YS, et al
    Risk of type 1 diabetes mellitus in patients with atopic dermatitis: a nationwide population-based cohort study.
    Dermatology. 2023 Dec 20. doi: 10.1159/000535848.
    >> Share

  6. THYSSEN JP, Bewley A, Stander S, Castro C, et al
    Abrocitinib Provides Rapid and Sustained Improvement in Skin Pain and Is Associated With Improved Quality of Life Outcomes in Adult and Adolescent Patients With Moderate-to-Severe Atopic Dermatitis.
    Dermatology. 2023 Dec 11. doi: 10.1159/000535285.
    >> Share

    November 2023
  7. BERNA-RICO E, Fiz-Benito E, Busto-Leis JM, Servera-Negre G, et al
    Effectiveness and safety of dupilumab in children under 6 years of age with moderate-to-severe atopic dermatitis: a retrospective real-world study.
    Dermatology. 2023 Nov 30. doi: 10.1159/000535282.
    >> Share

  8. CHENG Y, Lu JW, Wang JH, Loh CH, et al
    Associations of atopic dermatitis with attention deficit/hyperactivity disorder and autism spectrum disorder: a systematic review and meta-analysis.
    Dermatology. 2023 Nov 8. doi: 10.1159/000533366.
    >> Share

    October 2023
  9. IAMSUMANG W, Chanprapaph K, Sukasem C, Satapornpong P, et al
    Genotypic and phenotypic characteristics of co-trimoxazole-induced cutaneous adverse reactions.
    Dermatology. 2023 Oct 4. doi: 10.1159/000534342.
    >> Share

    September 2023
  10. LIM JJ, Lim YYE, Ng JY, Malipeddi P, et al
    Burgers, fast foods, and increased associated risk for atopic dermatitis: A cross-sectional study of dietary habits among young Chinese adults in Singapore/Malaysia.
    Dermatology. 2023 Sep 4. doi: 10.1159/000533942.
    >> Share

    August 2023
  11. JACOBSON ME, Myles IA, Paller AS, Eichenfield LF, et al
    A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 16-Week Trial to Evaluate the Efficacy and Safety of FB-401 in Children, Adolescent and Adult Subjects (Ages 2 Years and Older) with Mild to Moderate Atopic Dermatitis.
    Dermatology. 2023 Aug 14. doi: 10.1159/000532054.
    >> Share

    January 2023
  12. ZHANG DG, Zahid JA, Ali Z, Thomsen SF, et al
    Risk of Atopic Disorders in Patients with Chronic Urticaria: A Systematic Review and Meta-Analysis.
    Dermatology. 2023;239:32-44.
    >> Share

  13. GAU SY, Chan WL, Tsai JD
    Risk of Atopic Diseases in Patients with Hidradenitis Suppurativa: A Systematic Review and Meta-Analysis of Observational Studies.
    Dermatology. 2023;239:314-322.
    >> Share

  14. STADLER PC, Oschmann A, Kerl-French K, Maul JT, et al
    Acute Generalized Exanthematous Pustulosis: Clinical Characteristics, Pathogenesis, and Management.
    Dermatology. 2023;239:328-333.
    >> Share

  15. HAMMAD H, Krausz J, Barcan M, Fisher S, et al
    Adult Henoch-Schonlein Purpura: Comprehensive Assessment of Demographic, Clinical, and Histopathological Features as Predictors for Systemic Involvement.
    Dermatology. 2023;239:609-615.
    >> Share

  16. SU Z, Zeng YP
    Dupilumab-Associated Psoriasis and Psoriasiform Manifestations: A Scoping Review.
    Dermatology. 2023;239:646-657.
    >> Share

  17. SANCHEZ-DIAZ M, Salazar-Nievas MC, Molina-Leyva A, Arias-Santiago S, et al
    Risk Factors of Quality-Of-Life and Sexual Function Impairment in Chronic Spontaneous Urticaria Patients: Cross-Sectional Study.
    Dermatology. 2023;239:601-608.
    >> Share

  18. GAO Z, Dou Y, Zhao P, Wang CJ, et al
    Successful Treatment of Prurigo Nodularis by Dupilumab: Report of 24 Patients.
    Dermatology. 2023;239:658-663.
    >> Share

  19. LEDUCQ S, Dugard A, Allemang-Trivalle A, Giraudeau B, et al
    Design and Methodological Issues of Within-Person (Split-Body) Randomized Controlled Trials Evaluating a Topical Treatment: A Systematic Review.
    Dermatology. 2023;239:720-731.
    >> Share

  20. KURZ B, Schreiver I, Siewert K, Haslboeck B, et al
    Investigation of Adverse Reactions in Tattooed Skin through Histological and Chemical Analysis.
    Dermatology. 2023;239:782-793.
    >> Share

  21. RICHTER C, Hafner J, Schuermann M, Tanadini M, et al
    Dupilumab for Chronic Prurigo: Case Series on Effectiveness, Safety, and Quality of Life.
    Dermatology. 2023;239:811-817.
    >> Share

  22. MOSTMANS Y, Richert B, De Maertelaer V, Saidi I, et al
    Chronic Spontaneous Urticaria in Belgium: Deciphering the Clinical Profile and Treatment of Patients Visiting an Urban City Immunology Department.
    Dermatology. 2023;239:926-936.
    >> Share

    September 2022
  23. LUGOVIC-MIHIC L, Mestrovic-Stefekov J, Cvitanovic H, Bulat V, et al
    The COVID-19 Pandemic and Recent Earthquake in Zagreb Together Significantly Increased the Disease Severity of Patients with Atopic Dermatitis.
    Dermatology. 2022 Sep 1:1-8. doi: 10.1159/000525901.
    >> Share

    June 2022
  24. SHIH YC, Yeh MC, Yang FA, Chen HC, et al
    Efficacy and Safety of Multiple Dupilumab Dose Regimens in Patients with Moderate-To-Severe Atopic Dermatitis: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.
    Dermatology. 2022 Jun 13:1-13. doi: 10.1159/000524608.
    >> Share

    May 2022
  25. LUCAS R, Szklenar M, Mihaly J, Szegedi A, et al
    Plasma Levels of Bioactive Vitamin D and A5 Ligands Positively Correlate with Clinical Atopic Dermatitis Markers.
    Dermatology. 2022 May 24:1-8. doi: 10.1159/000524343.
    >> Share

  26. SAHIN U, Reeve K, Tochtermann G, Kilanowski K, et al
    HautTief Multidisciplinary Educational Program for Patients with Psoriasis or Atopic Dermatitis: A Randomized Controlled Study.
    Dermatology. 2022 May 9:1-10. doi: 10.1159/000524225.
    >> Share

    March 2022
  27. YE C, Gu H, Li M, Chen R, et al
    Air Pollution and Weather Conditions Are Associated with Daily Outpatient Visits of Atopic Dermatitis in Shanghai, China.
    Dermatology. 2022 Mar 21:1-11. doi: 10.1159/000522491.
    >> Share

    January 2022
  28. VAN MIERLO MMF, Pardo LM, Fieten KB, van den Broek TJ, et al
    The Skin and Nose Microbiome and Its Association with Filaggrin Gene Mutations in Pediatric Atopic Dermatitis.
    Dermatology. 2022 Jan 18:1-11. doi: 10.1159/000520978.
    >> Share

  29. SESTAN M, Srsen S, Kifer N, Sapina M, et al
    Persistence and Severity of Cutaneous Manifestations in IgA Vasculitis Is Associated with Development of IgA Vasculitis Nephritis in Children.
    Dermatology. 2022;238:340-346.
    >> Share

  30. COLLIER E, Sangar S, Shen A, Davis J, et al
    A Closer Look at Bleach Baths: Evidence, Tub Size, and Instructions.
    Dermatology. 2022;238:603-608.
    >> Share

  31. BRONZ G, Rinoldi PO, Lavagno C, Bianchetti MG, et al
    Skin Eruptions in Acute Hemorrhagic Edema of Young Children: Systematic Review of the Literature.
    Dermatology. 2022;238:397-403.
    >> Share

  32. ANDERSON J, Maghfour J, Hamp A, Christensen A, et al
    From the Cochrane Library: Emollients and Moisturizers for Eczema.
    Dermatology. 2022;238:594-596.
    >> Share

  33. ROGOWSKA P, Sobjanek M, Slawinska M, Nowicki RJ, et al
    Tattoos Dermatological Complications: Analysis of 53 Cases from Northern Poland.
    Dermatology. 2022;238:799-806.
    >> Share

  34. SUO H, Jiang B, Sun X, Dong J, et al
    Comparing the Accuracy of ABCD-10 and SCORTEN in Predicting the In-Hospital Mortality of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Multi-Institutional Study from Central China.
    Dermatology. 2022;238:736-744.
    >> Share

  35. SONG Z, Nie Y, Yang L, Tao J, et al
    Predicting Severe Renal and Gastrointestinal Involvement in Childhood Immunoglobulin A Vasculitis with Routine Laboratory Parameters.
    Dermatology. 2022;238:745-752.
    >> Share

  36. FROLUNDE AS, Wiis MAK, Ben Abdallah H, Elsgaard S, et al
    Non-Atopic Chronic Nodular Prurigo (Prurigo Nodularis Hyde): A Systematic Review of Best-Evidenced Treatment Options.
    Dermatology. 2022;238:950-960.
    >> Share

  37. SLODOWNIK D, Levi A, Lapidoth M, Moshe S, et al
    Occupational Chronic Contact Dermatitis Successfully Treated with Dupilumab: A Case Series.
    Dermatology. 2022;238:1073-1075.
    >> Share

    December 2021
  38. XU D, Stengel R, Sun P
    Effectiveness of Emollients in the Prevention of Atopic Dermatitis in Infants: A Meta-Analysis.
    Dermatology. 2021 Dec 6:1-6. doi: 10.1159/000519923.
    >> Share

    October 2021
  39. CHIRICOZZI A, Gori N, Di Nardo L, Antonelli F, et al
    Therapeutic Impact and Management of Persistent Head and Neck Atopic Dermatitis in Dupilumab-Treated Patients.
    Dermatology. 2021 Oct 28:1-8. doi: 10.1159/000519361.
    >> Share

    January 2021
  40. MCPHIE ML, Bridgman AC, Kirchhof MG
    A Review of Skin Disease in Schizophrenia.
    Dermatology. 2021;237:248-261.
    >> Share

  41. DE LUIGI G, Zgraggen L, Kottanattu L, Simonetti GD, et al
    Skin and Mucous Membrane Eruptions Associated with Chlamydophila Pneumoniae Respiratory Infections: Literature Review.
    Dermatology. 2021;237:230-235.
    >> Share

  42. KRIDIN K, Ludwig RJ, Tzur Bitan D, Cohen AD, et al
    A History of Asthma Increases the Risk of Bullous Pemphigoid: Insights from a Large Population-Based Study.
    Dermatology. 2021;237:921-928.
    >> Share

  43. GISONDI P, Geat D, Mattiucci A, Lombardo F, et al
    Incidence of Adverse Cutaneous Reactions to Epidermal Growth Factor Receptor Inhibitors in Patients with Non-Small-Cell Lung Cancer.
    Dermatology. 2021;237:929-933.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016